These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4935067)

  • 21. Maintenance therapy and schizophrenia.
    Leff JP
    Br J Psychiatry; 1975; Spec No 9():55-8. PubMed ID: 241453
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychodynamic aspects in young patients suffering from peripheral vascular occlusions.
    Köhle K; Simons C
    Psychother Psychosom; 1970; 18(1):313-20. PubMed ID: 4938753
    [No Abstract]   [Full Text] [Related]  

  • 23. PHENOTHIAZINE REDUCTION AS A CAUSE OF REHOSPITALIZATION.
    GANTZ RS; BIRKETT DP
    Arch Gen Psychiatry; 1965 Jun; 12():586-8. PubMed ID: 14286887
    [No Abstract]   [Full Text] [Related]  

  • 24. Toward assessment of personal competence and incompetence in life situations.
    Sundberg ND; Snowden LR; Reynolds WM
    Annu Rev Psychol; 1978; 29():179-221. PubMed ID: 341780
    [No Abstract]   [Full Text] [Related]  

  • 25. Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients.
    Klein DF; Rosen B
    Arch Gen Psychiatry; 1973 Oct; 29(4):480-5. PubMed ID: 4583948
    [No Abstract]   [Full Text] [Related]  

  • 26. The management of white certified schizophrenic patients in the community of the Witwatersrand.
    Pearlman T
    S Afr Med J; 1970 Oct; 44(41):1181-2. PubMed ID: 5497512
    [No Abstract]   [Full Text] [Related]  

  • 27. Pre-morbid adjustments, schizoid personality and onset of illness as predictors of post-hospitalization functioning.
    Longabaugh R; Eldred SH
    J Psychiatr Res; 1973 Jun; 10(1):19-29. PubMed ID: 4147128
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of butaperazine in chronic schizophrenia.
    Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
    Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
    [No Abstract]   [Full Text] [Related]  

  • 29. Ward atmosphere and outcome of treatment of acute schizophrenia.
    Kellam SG; Goldberg SC; Schooler NR; Berman A; Shmelzer JL
    J Psychiatr Res; 1967 Jun; 5(2):145-63. PubMed ID: 6056817
    [No Abstract]   [Full Text] [Related]  

  • 30. Research design for analyzing drug-environment-behavior interactions.
    Liberman RP; Davis J; Moon W; Moore J
    J Nerv Ment Dis; 1973 Jun; 156(6):432-9. PubMed ID: 4711622
    [No Abstract]   [Full Text] [Related]  

  • 31. EFFECTS OF PSYCHOTROPIC DRUGS ON LONG-TERM ADJUSTMENT. A REVIEW.
    GITTELMAN RK; KLEIN DF; POLLACK M
    Psychopharmacologia; 1964 Apr; 5():317-38. PubMed ID: 14151546
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates.
    Hogarty GE; Goldberg SC
    Arch Gen Psychiatry; 1973 Jan; 28(1):54-64. PubMed ID: 4345664
    [No Abstract]   [Full Text] [Related]  

  • 33. Trial of maintenance therapy in schizophrenia.
    Leff JP; Wing JK
    Br Med J; 1971 Sep; 3(5775):599-604. PubMed ID: 4936538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premorbid adjustment, phenothiazine treatment, and remission in acute schizophrenics.
    Evans JR; Rodnick EH; Goldstein MJ; Judd LL
    Arch Gen Psychiatry; 1972 Oct; 27(4):486-90. PubMed ID: 4342117
    [No Abstract]   [Full Text] [Related]  

  • 35. Short vs long hospitalization. A prospective controlled study. I. The preliminary results of a one-year follow-up schizophrenics.
    Glick ID; Hargreaves WA; Goldfield MD
    Arch Gen Psychiatry; 1974 Mar; 30(3):363-9. PubMed ID: 4813139
    [No Abstract]   [Full Text] [Related]  

  • 36. The effectiveness of a new drug, mesoridazine, and chlorpromazine with behavior problems in children.
    Kenny TJ; Badie D; Baldwin RW
    J Nerv Ment Dis; 1968 Sep; 147(3):316-21. PubMed ID: 4878442
    [No Abstract]   [Full Text] [Related]  

  • 37. Functional speech disorders and personality: a decade of research.
    Bloch EL; Goodstein LD
    J Speech Hear Disord; 1971 Aug; 36(3):295-314. PubMed ID: 4935721
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative comparison of clinical effectiveness of chlorpromazine and promazine.
    GILMORE TH; SHATIN L
    J Ment Sci; 1959 Apr; 105(439):508-10. PubMed ID: 13665315
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

  • 40. Embedded figures performance of schizophrenics as a function of chronicity, premorbid adjustment, diagnosis, and medication.
    Magaro PA; Vojtisek JE
    J Abnorm Psychol; 1971 Apr; 77(2):184-91. PubMed ID: 4927655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.